Highlights
NASDAQ: CTIC       Cti Biopharm Corp
Last Price Today's Change   Day's Range   Trading Volume
3.14   -0.03 (0.95%)  3.10 - 3.19  71,439

Overview

 
Avg Volume (4 weeks):4,540,280
4 Weeks Range:1.97 - 3.68
4 Weeks Price Volatility (%):
68.42%
52 Weeks Range:0.62 - 3.68
52 Weeks Price Volatility (%):
82.35%
Average Price Target: 3.00
Price Target Upside/Downside: -0.14

Headlines



No recent Headlines for this stock.


Business Background

CTI Biopharma Corp is a biopharmaceutical company focused on the development and commercialization of less toxic, more effective cancer therapies. The company's therapeutic area is blood-related cancers. One of the company's products, Pixantrone (PIXUVRI), received conditional marketing approval in the EU in 2012 to treat refractory aggressive B-cell non-Hodgkin lymphoma. Another product is Pacritinib, an oral tyrosine kinase inhibitor to treat mutations such as Janus associated kinase 2 (JAK2) and FMS-like tyrosine kinase 3 (FLT3).

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

3363  2441  444  3154 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 LK 1.38+1.38 
 OAS 0.155-0.014 
 NIO 29.68+2.17 
 NOK 3.326-0.724 
 PINS 65.265+16.015 
 F 8.165+0.465 
 GE 7.594+0.174 
 AMTD 39.97-0.85 
 PGNX 4.10-0.425 
 XOG 0.271-0.062